SCHEMBL7347598

SCHEMBL7347598

O=C(O)CCN(C1(C(=O)NO)CCOCC1)S(=O)(=O)c1ccc(-c2ccc(Cl)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 10/20 0.55
MMP13 P45452 10/20 0.46
MMP2 P08253 5/20 0.46
MMP9 P14780 5/20 0.46
MMP3 P08254 4/20 0.46
MMP8 P22894 4/20 0.46
MMP14 P50281 4/20 0.46
MMP7 P09237 2/20 0.46
ABCB11 O95342 1/20 0.46
MMP10 P09238 1/20 0.46
ADAM17 P78536 1/20 0.46
ADAMTS5 Q9UNA0 4/20 0.39
DAGLA Q9Y4D2 1/20 0.39
MEP1B Q16820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809651 0.91 MMP1 (0.68) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7352297 0.90 MMP1 (0.68) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7352211 0.88 MMP1 (0.45) MMP1MMP13MMP2MMP9MMP3
SCHEMBL6873149 0.82 MMP1 (0.70) MMP1MMP13MMP2MMP9MMP3
SCHEMBL14302914 0.81 MMP1 (0.66) MMP1MMP13MMP2MMP9MMP3
SCHEMBL6818064 0.81 MMP1 (0.78) MMP1MMP13MMP2MMP9MMP3
SCHEMBL6695057 0.81 MMP1 (0.81) MMP1MMP13MMP2MMP9MMP3
SCHEMBL3987272 0.81 MMP1 (0.68) MMP1MMP13MMP2MMP9MMP3
SCHEMBL26434 0.81 MMP1 (0.83) MMP1MMP13MMP2MMP9MMP3
SCHEMBL6813516 0.80 MMP1 (0.54) MMP1MMP13MMP2MMP9MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0895988-B1 Arylsulfonylamino hydroxamic acid derivatives PFIZER PROD INC (US) 2002-05-22 EP disclosed
US-6107337-A ANTIARTHRITIC AGENTS; ANTICARCINOGENIC AGENTS PFIZER INC. (US) 2000-08-22 US disclosed
EP-0895988-A1 Arylsulfonylamino hydroxamic acid derivatives Pfizer Products Inc. (US) 1999-02-10 EP disclosed